- Home
- CRVO vs JEQ Comparison
CRVO vs JEQ Comparison
Compare CRVO & JEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- JEQ
- Stock Information
- Founded
- CRVO 2001
- JEQ 1990
- Country
- CRVO United States
- JEQ United States
- Employees
- CRVO N/A
- JEQ N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- JEQ Air Freight/Delivery Services
- Sector
- CRVO Health Care
- JEQ Consumer Discretionary
- Exchange
- CRVO Nasdaq
- JEQ Nasdaq
- Market Cap
- CRVO 98.3M
- JEQ 79.2M
- IPO Year
- CRVO N/A
- JEQ N/A
- Fundamental
- Price
- CRVO $2.11
- JEQ $5.66
- Analyst Decision
- CRVO Buy
- JEQ
- Analyst Count
- CRVO 8
- JEQ 0
- Target Price
- CRVO $38.75
- JEQ N/A
- AVG Volume (30 Days)
- CRVO 303.4K
- JEQ 32.0K
- Earning Date
- CRVO 11-12-2024
- JEQ 01-01-0001
- Dividend Yield
- CRVO N/A
- JEQ 7.05%
- EPS Growth
- CRVO N/A
- JEQ N/A
- EPS
- CRVO N/A
- JEQ N/A
- Revenue
- CRVO $10,066,550.00
- JEQ N/A
- Revenue This Year
- CRVO $34.17
- JEQ N/A
- Revenue Next Year
- CRVO N/A
- JEQ N/A
- P/E Ratio
- CRVO N/A
- JEQ N/A
- Revenue Growth
- CRVO 116.29
- JEQ N/A
- 52 Week Low
- CRVO $1.80
- JEQ $4.99
- 52 Week High
- CRVO $26.38
- JEQ $6.39
- Technical
- Relative Strength Index (RSI)
- CRVO 28.68
- JEQ 42.69
- Support Level
- CRVO $2.03
- JEQ $5.61
- Resistance Level
- CRVO $2.17
- JEQ $5.73
- Average True Range (ATR)
- CRVO 0.16
- JEQ 0.06
- MACD
- CRVO 0.30
- JEQ -0.01
- Stochastic Oscillator
- CRVO 23.08
- JEQ 25.93
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.